Tarsus Pharmaceuticals, Inc. - COM (TARS)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
40.1M
Holdings value Q2 2024
$1.09B
Value change Q2 2024
+$12.5M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
147
Number of buys Q2 2024
22
Number of sells Q2 2024
-12
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.15M $70.7M +$17.1M $32.89 33
2024 Q2 40.1M $1.09B +$12.5M $27.18 149
2024 Q1 39.2M $1.42B +$258M $36.35 154
2023 Q4 32.1M $651M +$49.6M $20.25 114
2023 Q3 29.8M $529M +$139M $17.77 106
2023 Q2 21.4M $387M +$39.2M $18.07 92
2023 Q1 20.1M $252M -$6.02M $12.57 73
2022 Q4 20.5M $301M +$5.06M $14.66 67
2022 Q3 20.5M $351M +$9.27M $17.12 73
2022 Q2 20M $292M +$98.8M $14.60 71
2022 Q1 13.2M $222M -$29.6M $16.82 50
2021 Q4 13.1M $294M +$4.32M $22.50 43
2021 Q3 12.9M $277M -$12.4M $21.55 43
2021 Q2 13.1M $379M +$8.24M $28.98 44
2021 Q1 12.8M $410M -$214K $32.23 41
2020 Q4 12.8M $524M +$524M $41.33 39